These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2669362)

  • 1. Metabolic fate of the oral hypoglycaemic agent, midaglizole, in rats.
    Fujimaki M; Ishigaki N; Hakusui H
    Xenobiotica; 1989 Jun; 19(6):609-25. PubMed ID: 2669362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the metabolites of a new hypoglycaemic agent, midaglizole, in dogs.
    Nakaoka M; Hakusui H
    Xenobiotica; 1987 Nov; 17(11):1329-39. PubMed ID: 3433802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of an imidazole fungicide (prochloraz) in the rat after oral administration.
    Laignelet L; Rivière JL; Lhuguenot JC
    Food Chem Toxicol; 1992 Jul; 30(7):575-83. PubMed ID: 1521831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of midaglizole (DG-5128). A new type of oral hypoglycemic drug in healthy subjects.
    Kawazu S; Suzuki M; Negishi K; Watanabe T; Ishii J
    Diabetes; 1987 Feb; 36(2):216-20. PubMed ID: 3542646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion.
    Atsumi R; Suzuki W; Hakusui H
    Xenobiotica; 1991 Sep; 21(9):1159-69. PubMed ID: 1788984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of 14C-cibenzoline in dogs and rats.
    Loh AC; Williams TH; Tilley JW; Sasso GJ; Szuna AJ; Carbone JJ; Toome V; Leinweber FJ
    Drug Metab Dispos; 1986; 14(3):325-30. PubMed ID: 2872033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo metabolism of the antianxiolytic agent fenobam in the rat.
    Wu WN; McKown LA; O'Neill PJ
    J Pharm Sci; 1995 Feb; 84(2):185-9. PubMed ID: 7738798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of methylphenidate in dog and rat.
    Egger H; Bartlett F; Dreyfuss R; Karliner J
    Drug Metab Dispos; 1981; 9(5):415-23. PubMed ID: 6117439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism and excretion of prochloraz, an imidazole-based fungicide, in the rat.
    Needham D; Challis IR
    Xenobiotica; 1991 Nov; 21(11):1473-82. PubMed ID: 1763521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.
    Paul H; Illing A; House ES
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans.
    Malfatti MA; Kulp KS; Knize MG; Davis C; Massengill JP; Williams S; Nowell S; MacLeod S; Dingley KH; Turteltaub KW; Lang NP; Felton JS
    Carcinogenesis; 1999 Apr; 20(4):705-13. PubMed ID: 10223203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new hypoglycemic agent, midaglizole, blunts diabetic platelet aggregation: a possible role of alpha 2 blockade.
    Inaba M; Katayama S; Kawazu S; Suzuki M; Negishi K; Ishii J
    Diabetes Res Clin Pract; 1989 Sep; 7(3):235-41. PubMed ID: 2575025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
    Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
    Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.